/PRNewswire/ Based on recent research in the Regenerative Medicines market, Lucintel is pleased to announce Vomaris Innovation s Procellera® FlexEFit™.
Vomaris Innovation s Bioelectric Procellera® FlexEFit™ Antibacterial Wound Dressing Receives 2021 Product Innovation Award by Lucintel prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies
ACCESSWIRE
19 May 2021, 20:05 GMT+10
Clinical Research Organization, Accerise Inc., Has Been Retained To Work With RepliCel and Its Other Service Providers To Prepare Study Documentation, Plans, and Approvals for Clinical Evaluation by Multiple Clinical Sites in Japan
VANCOUVER, BC / ACCESSWIRE / May 19, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that it has retained leading clinical research organization, Accerise Inc, with offices in Tokyo and Osaka, to lead the planning and preparations for clinical research studies of RepliCel s skin rejuvenation (RCS-01) and tendon regeneration (RCT-01) cell therapy products in Japan.